SECOND SIGHT MED PRODS INC - COM NEW (EYES)

CUSIP: 81362J209

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM NEW
Total 13F shares
2,079,661
Share change
-476,408
Total reported value
$4,221,000
Put/Call ratio
9.2%
Price per share
$2.03
Number of holders
27
Value change
-$838,864
Number of buys
16
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 81362J209?
CUSIP 81362J209 identifies EYES - SECOND SIGHT MED PRODS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM NEW (EYES) as of Q2 2022

As of 30 Jun 2022, SECOND SIGHT MED PRODS INC - COM NEW (EYES) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,079,661 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., STATE STREET CORP, CITADEL ADVISORS LLC, HRT FINANCIAL LP, Tower Research Capital LLC (TRC), and NORTHERN TRUST CORP. This page lists 27 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.